A Single Dose of Oral BCG Moreau Fails to Boost Systemic IFN-γ Responses to Tuberculin in Children in the Rural Tropics: Evidence for a Barrier to Mucosal Immunization.
|
A Single Dose of Oral BCG Moreau Fails to Boost Systemic IFN-γ Responses to Tuberculin in Children in the Rural Tropics: Evidence for a Barrier to Mucosal Immunization.
|
Authors:
Address: Centro de Investigaciónes FEPIS, Esmeraldas Quinindé, Ecuador.
Journal:
Publication:
Free Text: A Single Dose of Oral BCG Moreau Fails to Boost Systemic IFN-γ Responses to Tuberculin in Children in the Rural Tropics: Evidence for a Barrier to Mucosal Immunization.
Immune Responses to Oral vaccines are impaired in populations living in conditions of poverty in developing countries, and there is Evidence that concurrent geohelminth infections may contribute to this effect. We vaccinated 48 Children living in Rural communities in Ecuador with a Single oral Dose of 100 mg of BCG Moreau RDJ and measured the frequencies of Tuberculin-stimulated peripheral blood mononuclear cells expressing IFN-γ before and after vaccination. Vaccinated children had active ascariasis (n = 20) or had been infected but received short- (n = 13) or long-term (n = 15) repeated treatments with albendazole prior to vaccination to treat ascariasis. All children had a BCG scar from neonatal vaccination. There was no evidence of a Boosting of postvaccination IFN-γ responses in any of the 3 study groups. Our data provide support for the presence of a Barrier to oral vaccination among children from the rural Tropics that appeared to be independent of concurrent ascariasis.
TraveldoctorOnline 2001 • Disclaimer • webmaster
The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.
